Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 1

Status

Completed 5

Sponsor Class

NIH 4OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Plasma cell 57Lymphoid 19CNS 16Genitourinary 15Gastrointestinal 15Sarcoma 14Other hematologic neoplasm 13Thoracic 9Dermatologic 8Myeloid 5Gynecologic 5Endocrine 4Classical hematology 4NET 2Head & Neck 2Breast 2Tumor-Agnostic 1Other solid neoplasm 1

Conditions

Ovarian Neoplasms 2Endometrial Neoplasms 2Carcinoma, Ovarian Epithelial 2Sarcoma, Endometrial Stromal 1Sarcoma 1Recurrent Uterine Corpus Sarcoma 1

Interventions

Paclitaxel 233Carboplatin 217Bevacizumab 139Cisplatin 136pembrolizumab 89Gemcitabine 69olaparib 54Docetaxel 47Topotecan 44Radiotherapy 43liposomal doxorubicin 41Taxes 41niraparib 38Cyclophosphamide 36Doxorubicin 30Drug Therapy 29Letrozole 28Nivolumab 27Magnetic Resonance Spectroscopy 25Immunoglobulin G 25Disulfides 24Oxaliplatin 23Albumin-Bound Paclitaxel 23durvalumab 22apatinib 21Etoposide 21Brachytherapy 21lenvatinib 20camrelizumab 20Specimen Handling 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Thalidomide × Gynecologic × Clear all
NCT00025220 2019-07-23

Thalidomide in Treating Patients With Recurrent or Persistent Cancer of the Uterus

National Cancer Institute (NCI)

Phase 2 Completed
60 enrolled
GynecologicSarcoma

Recurrent Uterine Corpus Sarcoma

NCT00004876 2013-08-26

Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer

National Cancer Institute (NCI)

Phase 2 Completed
30 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00006005 2013-06-21

Thalidomide in Treating Patients With Gynecologic Sarcomas

National Cancer Institute (NCI)

Phase 2 Completed
GynecologicSarcoma

Sarcoma, Endometrial Neoplasms, Sarcoma, Endometrial Stromal

NCT00016224 2013-06-18

Thalidomide in Treating Patients With Refractory or Resistant Epithelial Ovarian Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00025467 2013-01-24

Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer

National Cancer Institute (NCI)

Phase 2 Completed
60 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡